These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

388 related items for PubMed ID: 11362986

  • 1. FDA triple header. Food and Drug Administration.
    Smart T.
    GMHC Treat Issues; 1995 Nov; 9(11):1-3. PubMed ID: 11362986
    [Abstract] [Full Text] [Related]

  • 2. FDA antiviral advisory hearings on lamivudine (Epivir, 3TC), saquinavir (Invirase), stavudine (Zerit, d4T), November 6-8. Food and Drug Administration.
    AIDS Treat News; 1995 Oct 20; (no 233):4-5. PubMed ID: 11363038
    [Abstract] [Full Text] [Related]

  • 3. Potent new AIDS drugs underscore promise of combination therapy.
    AIDS Alert; 1996 Jan 20; 11(1):1-4. PubMed ID: 11363225
    [Abstract] [Full Text] [Related]

  • 4. 3TC and saquinavir: we need them now.
    Baker R.
    BETA; 1995 Sep 20; ():3. PubMed ID: 11362889
    [Abstract] [Full Text] [Related]

  • 5. Protease inhibitors and prevention of cross resistance.
    Levin J.
    AIDS Treat News; 1995 Oct 06; (no 232):1-3. PubMed ID: 11362875
    [Abstract] [Full Text] [Related]

  • 6. New drugs for HIV infection.
    Med Lett Drugs Ther; 1996 Apr 12; 38(972):35-7. PubMed ID: 8606677
    [Abstract] [Full Text] [Related]

  • 7. Nipping HIV in the bud.
    Smart T.
    GMHC Treat Issues; 1996 Aug 12; 10(8):3-6. PubMed ID: 11363719
    [Abstract] [Full Text] [Related]

  • 8. Major protease inhibitor triple combination trial begins soon: CD4 under 200, AZT experienced, 3TC naive.
    James JS.
    AIDS Treat News; 1995 Dec 22; (no 237):3. PubMed ID: 11363075
    [Abstract] [Full Text] [Related]

  • 9. Top AIDS researchers' strategy for antiretroviral treatment.
    AIDS Alert; 1996 Sep 22; 11(9):97-100. PubMed ID: 11363728
    [Abstract] [Full Text] [Related]

  • 10. Back to the nukes.
    Smart T.
    GMHC Treat Issues; 1996 Feb 22; 10(2):6-7. PubMed ID: 11363383
    [Abstract] [Full Text] [Related]

  • 11. Update on HIV protease inhibitors.
    Vella S.
    AIDS Clin Care; 1995 Oct 22; 7(10):79-82, 88. PubMed ID: 11362832
    [Abstract] [Full Text] [Related]

  • 12. Europe out of step with the US.
    Alcorn K.
    J Int Assoc Physicians AIDS Care; 1996 Jan 22; 2(1):33-4. PubMed ID: 11363328
    [Abstract] [Full Text] [Related]

  • 13. Roche submits NDA for Invirase.
    J Int Assoc Physicians AIDS Care; 1995 Sep 22; 1(8):37-8. PubMed ID: 11362796
    [Abstract] [Full Text] [Related]

  • 14. 3TC approval may revive AZT's appeal.
    Vazquez E.
    Posit Aware; 1996 Sep 22; 7(1):8-9. PubMed ID: 11363136
    [Abstract] [Full Text] [Related]

  • 15. Combination therapy increases survival.
    Treat Rev; 1995 Nov 22; (no 20):2-3. PubMed ID: 11363019
    [Abstract] [Full Text] [Related]

  • 16. Lamivudine (3TC) approved for combination use with AZT.
    James JS.
    AIDS Treat News; 1995 Dec 01; (no 236):1-5. PubMed ID: 11363049
    [Abstract] [Full Text] [Related]

  • 17. Protease inhibitors shine in triple combinations.
    AIDS Alert; 1996 Mar 01; 11(3):31-2. PubMed ID: 11363243
    [Abstract] [Full Text] [Related]

  • 18. Ritonavir: first to prolong survival.
    MacDougall DS.
    J Int Assoc Physicians AIDS Care; 1996 Apr 01; 2(4):38-44. PubMed ID: 11363517
    [Abstract] [Full Text] [Related]

  • 19. FDA approves 3TC and saquinavir. Food and Drug Administration.
    Baker R.
    BETA; 1995 Dec 01; ():5, 9. PubMed ID: 11363011
    [Abstract] [Full Text] [Related]

  • 20. Treatment options for human immunodeficiency virus.
    Heins JR.
    S D J Med; 1996 Feb 01; 49(2):51-2. PubMed ID: 9122670
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.